Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact

M MacLeod, A Papi, M Contoli, B Beghé, BR Celli… - …, 2021 - Wiley Online Library
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …

[HTML][HTML] COVID-19 pandemic and non invasive respiratory management: every Goliath needs a David. An evidence based evaluation of problems

JC Winck, N Ambrosino - Pulmonology, 2020 - Elsevier
Background and aim The war against Covid-19 is far from won. This narrative review
attempts to describe some problems with the management of Covid-19 induced acute …

ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure

S Oczkowski, B Ergan, L Bos, M Chatwin… - European respiratory …, 2022 - Eur Respiratory Soc
Background High-flow nasal cannula (HFNC) has become a frequently used noninvasive
form of respiratory support in acute settings; however, evidence supporting its use has only …

[HTML][HTML] High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial

A Cortegiani, F Longhini, F Madotto, P Groff, R Scala… - Critical Care, 2020 - Springer
Background The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute
hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear …

[Translated article] Spanish COPD guidelines (GesEPOC) 2021 update. Diagnosis and treatment of COPD exacerbation syndrome

JJ Soler-Cataluña, P Piñera, JA Trigueros… - Archivos de …, 2022 - Elsevier
This article details the GesEPOC 2021 recommendations on the diagnosis and treatment of
COPD exacerbation syndrome (CES). The guidelines propose a definition-based syndromic …

[HTML][HTML] Non-invasive respiratory support paths in hospitalized patients with COVID-19: proposal of an algorithm

JC Winck, R Scala - Pulmonology, 2021 - Elsevier
Abstract COVID-19 related Acute Respiratory Failure, may be successfully treated with
Conventional Oxygen therapy, High Flow Nasal Cannula, Continuous Positive Airway …

[HTML][HTML] Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis

A Bruni, E Garofalo, V Zuccalà, G Currò, C Torti… - World Journal of …, 2020 - Springer
Background Since its first documentation, a novel coronavirus (SARS-CoV-2) infection has
emerged worldwide, with the consequent declaration of a pandemic disease (COVID-19) …

High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future

L Spicuzza, M Schisano - Therapeutic advances in chronic …, 2020 - journals.sagepub.com
Conventional oxygen therapy (COT) and noninvasive ventilation (NIV) have been
considered for decades as frontline treatment for acute or chronic respiratory failure …

[HTML][HTML] Oxygenation strategies during flexible bronchoscopy: a review of the literature

C Pelaia, A Bruni, E Garofalo, S Rovida, E Arrighi… - Respiratory …, 2021 - Springer
During flexible fiberoptic bronchoscopy (FOB) the arterial partial pressure of oxygen can
drop, increasing the risk for respiratory failure. To avoid desaturation episodes during the …

High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial

F Longhini, C Pelaia, E Garofalo, A Bruni, R Placida… - Thorax, 2022 - thorax.bmj.com
Introduction High-flow nasal cannula (HFNC) provides benefits to patients undergoing
flexible bronchoscopy (FOB). We compared the effects of HFNC versus standard therapy …